影响骨质疏松患者用药依从性因素的系统综述
该系统综述检索截至2018年1月的文献,纳入124篇同行评议文章,评估影响抗骨质疏松药物依从性的因素,并按世界卫生组织用药依从性五个维度分类。依从性范围为12.9%至95.4%,共识别24个因素和139个子因素。与依从性较差相关的因素包括多重用药、高龄、对骨质疏松的误解、给药频率高、药物副作用、不同专科就诊、缺乏患者教育、当前吸烟和缺乏医疗保险;跌倒史与较高依从性相关。
要点
- 依从性范围12.9%至95.4%,双膦酸盐是被研究最多的药物类别(n=59,48%)。
- 与依从性较差相关的因素包括多重用药、高龄、对骨质疏松的误解、给药频率高和药物副作用。
- 临床医生需了解影响依从性的复杂因素以优化治疗结局。
核心结论
- 本综述识别了与骨质疏松患者用药依从性差相关的因素,临床医生需了解影响依从性的复杂因素以优化患者治疗结局。
研究设计与样本
- 系统综述,检索截至2018年1月发表于PubMed®、PsychINFO®、Embase®和CINAHL®的文献。
- 纳入考察抗骨质疏松药物依从性相关因素的同行评议文章,排除Meta分析、病例报告/系列和其他系统综述。
- 抗骨质疏松药物类别包括双膦酸盐、甲状旁腺激素相关类似物、地舒单抗、选择性雌激素受体调节剂、雌激素/孕激素治疗、降钙素和雷奈酸锶。
- 从2404篇文章中筛选出124篇相关文章,使用世界卫生组织用药依从性五个维度(疾病、患者、治疗、卫生系统和社经)对因素进行分类。
主要发现
- 用药依从性患病率范围为12.9%至95.4%。
- 共识别24个因素和139个子因素;双膦酸盐是被研究最多的药物类别(n=59,48%)。
- 与依从性较差相关的疾病相关因素包括多重用药;跌倒史与较高依从性相关。
- 与依从性较差相关的患者相关因素包括高龄和对骨质疏松的误解;治疗相关因素包括较高给药频率和药物副作用。
- 与依从性较差相关的卫生系统因素包括在不同医学专科接受诊疗和缺乏患者教育;社经因素包括当前吸烟和缺乏医疗保险覆盖。
关键数值与推荐
- 与依从性较差相关的因素:多重用药、高龄、对骨质疏松的误解、较高给药频率、药物副作用、不同医学专科诊疗、缺乏患者教育、当前吸烟、缺乏医疗保险覆盖。
- 与较高依从性相关的因素:跌倒史。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: The aim of this review was to identify factors that influence patients' adherence to anti-osteoporotic therapy. Factors identified that were associated with poorer medication adherence included polypharmacy, older age, and misconceptions about osteoporosis. Physicians need to be aware of these factors so as to optimize therapeutic outcomes for patients. INTRODUCTION: To identify factors that influence patients' adherence to anti-osteoporotic therapy. METHODS: A systematic review of literature was performed for articles published up till January 2018 using PubMed®, PsychINFO®, Embase®, and CINAHL®. Peer-reviewed articles which examined factors associated with anti-osteoporotic medication adherence were included. Classes of anti-osteoporotic therapy included bisphosphonates, parathyroid hormone-related analogue, denosumab, selective estrogen receptor modulators, estrogen/progestin therapy, calcitonin, and strontium ranelate. Meta-analyses, case reports/series, and other systematic reviews were excluded. Identified factors were classified using the World Health Organization's five dimensions of medication adherence (condition, patient, therapy, health-system, and socio-economic domains). RESULTS: Of 2404 articles reviewed, 124 relevant articles were identified. The prevalence of medication adherence ranged from 12.9 to 95.4%. Twenty-four factors with 139 sub-factors were identified. Bisphosphonates were the most well-studied class of medication (n = 59, 48%). Condition-related factors that were associated with poorer medication adherence included polypharmacy, and history of falls was associated with higher medication adherence. Patient-related factors which were associated with poorer medication adherence included older age and misconceptions about osteoporosis while therapy-related factors included higher dosing frequency and medication side effects. Health system-based factors associated with poorer medication adherence included care under different medical specialties and lack of patient education. Socio-economic-related factors associated with poorer medication adherence included current smoker and lack of medical insurance coverage. CONCLUSION: This review identified factors associated with poor medication adherence among osteoporotic patients. To optimize therapeutic outcomes for patients, clinicians need to be aware of the complexity of factors affecting medication adherence.
引用
- Yeam CT, Chia S, Tan HCC, et al. A systematic review of factors affecting medication adherence among patients with osteoporosis. Osteoporos Int. 2018. PMID: 30417253. doi:10.1007/s00198-018-4759-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。